Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.54 USD | -1.36% | +3.65% | -4.84% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.84% | 1.53B | |
+18.49% | 78.7B | |
+14.09% | 9.26B | |
-15.14% | 4.92B | |
+45.17% | 4.66B | |
+15.70% | 4.27B | |
+16.71% | 2.44B | |
-26.13% | 2.22B | |
+15.73% | 2.15B | |
-40.52% | 1.89B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Transcript : Supernus Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 04, 2021